STOCK TITAN

LADRX CORPORATION (LADX) Stock Price, News & Analysis

LADX OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
31 38 sessions, October 22, 2025 to October 26, 2026
Largest daily move
+5400% close of September 16, 2026
1-year change
-89% closing prices, October 22, 2025 to October 26, 2026
1-month change
+5400% closing prices, September 24, 2026 to October 26, 2026

Company Description

LADRX CORPORATION (OTC: LADX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $579.3K.

LADX has declined 89.0% over the past year. The last closing price was $0.0110.

For FY2024, LADRX CORPORATION reported net income of -$1.6M and diluted earnings per share of -$3.21.

This page collects what Stock Titan holds for LADX, including price data, latest news, financial highlights, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-89%
Performance 1 year
$579.3K

LADRX CORPORATION (LADX) closed at $0.0110 on October 26, 2026. Over the past 12 months, the price has lost 89.0%.

See what a $1,000 investment in LADX would be worth today

Average down calculator for LADX

LADX Metrics & Rankings

Price returns through October 26, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

SEC Filings

No SEC filings available for LADX.

Financial Highlights

operating income reached -$3.6M, and net income was -$1.6M. Diluted earnings per share stood at -$3.21. The company generated -$1.3M in operating cash flow. The current ratio was 0.37, measuring current assets divided by current liabilities.

-$1.6M
Net Income (FY2024)
-$1.3M
Operating Cash Flow
—
Revenue (FY2024)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in LADRX CORPORATION (LADX) currently stands at 214 shares, representing 0.0% of the float. Since October 2025, short interest has increased by 18.9%.

Days to Cover History

Last 12 Months

Days to cover for LADRX CORPORATION (LADX) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.

LADX Company Profile & Sector Positioning

LADRX CORPORATION (LADX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing LADX often look at related companies in the same sector, including LOBE SCIENCES LTD (LOBEF), AIBOTICS INC (AIBT), THERAPEUTIC SLTNS INTL (TSOI), BIO-PATH HOLDINGS INC (BPTH), and EMMAUS LIFE SCIENCES INC (EMMA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LADX's relative position within its industry.

Frequently Asked Questions

What is the current stock price of LADRX CORPORATION (LADX)?

The current stock price of LADRX CORPORATION (LADX) is $0.011 as of October 26, 2026.

What is the market cap of LADRX CORPORATION (LADX)?

The market cap of LADRX CORPORATION (LADX) is approximately $579.3K. Learn more about what market capitalization means .

What is the net income of LADRX CORPORATION (LADX)?

The FY2024 net income of LADRX CORPORATION (LADX) is -$1.6M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of LADRX CORPORATION (LADX)?

The diluted earnings per share (EPS) of LADRX CORPORATION (LADX) is -$3.21 for FY2024, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of LADRX CORPORATION (LADX)?

The operating cash flow of LADRX CORPORATION (LADX) is -$1.3M for FY2024, its most recent completed fiscal year. Learn about cash flow.

What is the current ratio of LADRX CORPORATION (LADX)?

The current ratio of LADRX CORPORATION (LADX), current assets divided by current liabilities, was 0.37 at the end of FY2024, its most recent completed fiscal year. Learn about liquidity ratios.

What is the operating income of LADRX CORPORATION (LADX)?

The operating income of LADRX CORPORATION (LADX) is -$3.6M for FY2024, its most recent completed fiscal year. Learn about operating income.